May 5, 2019
The Israel Securities Authority (ISA) announced on Sunday, May 5th 2019, that it had approved the possibility of raising capital through the issue of Yahash to partnerships in research and development.
March 15, 2019
Prof. Dedi Meiri, a lecturer and researcher in the field of medical cannabis at the Technion Institute of Technology, Haifa, and head of its Laboratory of Cancer Biology and Cannabinoid Research in the Biology Faculty, has been appointed as a member of the Scientific Advisory Board of Improdia.
February 12, 2019
Amndis has signed an Exclusive License Agreement with Yissum, the technology transfer company of The Hebrew University of Jerusalem. The company is developing a genomic-measurement diagnostic test based on an AI learning machine for the purpose of preventing unnecessary life-threatening surgery for head-and-neck cancer patients..
December 12, 2018
GHP’s portfolio includes companies whose source of technology is groundbreaking research from Israeli academic institutions, with an emphasis on life sciences and cancer-related developments in the early stages of clinical trials. The management strategy og GHP increases the value of the companies, focused on cancer research and personilized treatment. The group focuses on companies whose products require lenient regulatory processes, enabling short regulatory procedures, such as orphan drugs and compassionate medicines.Read More